FENTORA DIN 02408007
Status: Marketed
Holder: PHOENIX LABS UNLIMITED COMPANY
Molecule: FENTANYL (FENTANYL CITRATE)
Available to quote
Health Canada record
| Active ingredient(s) | FENTANYL (FENTANYL CITRATE) 100 MCG |
|---|---|
| Dosage form | Tablet (Effervescent) |
| Route | Sublingual; Buccal |
| Schedule | NARCOTICS (CDSA I) |
| Class | Human |
| ATC | N02AB03 FENTANYL |
| Original market date | 14-May-2014 |
| Current status date | 22-Jul-2026 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FENTANYL (FENTANYL CITRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02506963 | FENTANYL CITRATE INJECTION | JAMP PHARMA CORPORATION | Solution | FENTANYL (FENTANYL CITRATE) 50 MCG | Marketed |
| 02384124 | FENTANYL CITRATE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | FENTANYL (FENTANYL CITRATE) 50 MCG | Marketed |
| 02240434 | FENTANYL CITRATE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | FENTANYL (FENTANYL CITRATE) 50 MCG | Marketed |
| 02501554 | FENTANYL CITRATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | FENTANYL (FENTANYL CITRATE) 50 MCG | Marketed |
| 02496143 | FENTANYL INJECTION BP | STERIMAX INC | Solution | FENTANYL (FENTANYL CITRATE) 100 MCG | Marketed |
| 02496186 | FENTANYL INJECTION BP | STERIMAX INC | Solution | FENTANYL (FENTANYL CITRATE) 2500 MCG | Marketed |
| 02496178 | FENTANYL INJECTION BP | STERIMAX INC | Solution | FENTANYL (FENTANYL CITRATE) 1000 MCG | Marketed |
| 02496151 | FENTANYL INJECTION BP | STERIMAX INC | Solution | FENTANYL (FENTANYL CITRATE) 250 MCG | Marketed |
| 02408031 | FENTORA | PHOENIX LABS UNLIMITED COMPANY | Tablet (Effervescent) | FENTANYL (FENTANYL CITRATE) 600 MCG | Marketed |
| 02408058 | FENTORA | PHOENIX LABS UNLIMITED COMPANY | Tablet (Effervescent) | FENTANYL (FENTANYL CITRATE) 800 MCG | Marketed |
| 02408015 | FENTORA | PHOENIX LABS UNLIMITED COMPANY | Tablet (Effervescent) | FENTANYL (FENTANYL CITRATE) 200 MCG | Marketed |
| 02408023 | FENTORA | PHOENIX LABS UNLIMITED COMPANY | Tablet (Effervescent) | FENTANYL (FENTANYL CITRATE) 400 MCG | Marketed |
| 02364174 | ABSTRAL | PALADIN PHARMA INC. | Tablet | FENTANYL (FENTANYL CITRATE) 100 MCG | Cancelled Post Market |
| 02364212 | ABSTRAL | PALADIN PHARMA INC. | Tablet | FENTANYL (FENTANYL CITRATE) 600 MCG | Cancelled Post Market |
| 02364220 | ABSTRAL | PALADIN PHARMA INC. | Tablet | FENTANYL (FENTANYL CITRATE) 800 MCG | Cancelled Post Market |
| 02364204 | ABSTRAL | PALADIN PHARMA INC. | Tablet | FENTANYL (FENTANYL CITRATE) 400 MCG | Cancelled Post Market |
| 02364190 | ABSTRAL | PALADIN PHARMA INC. | Tablet | FENTANYL (FENTANYL CITRATE) 300 MCG | Cancelled Post Market |
| 02364182 | ABSTRAL | PALADIN PHARMA INC. | Tablet | FENTANYL (FENTANYL CITRATE) 200 MCG | Cancelled Post Market |
| 02126648 | FENTANYL CITRATE INJECTION U.S.P.-LIQ IV IM EPD | HOSPIRA HEALTHCARE ULC | Solution | FENTANYL (FENTANYL CITRATE) 50 MCG | Cancelled Post Market |
| 02385406 | FENTANYL CITRATE INJECTION USP | HIKMA CANADA LIMITED | Solution | FENTANYL (FENTANYL CITRATE) 50 MCG | Dormant |
| 00888346 | FENTANYL CITRATE INJECTION USP | PFIZER CANADA ULC | Solution | FENTANYL (FENTANYL CITRATE) 50 MCG | Cancelled Post Market |
| 01988778 | FENTANYL CITRATE INJECTION USP 50MCG/ML | DAVID BULL LABORATORIES (CANADA) INC. | Liquid | FENTANYL (FENTANYL CITRATE) 50 MCG | Cancelled Post Market |
| 02408554 | INSTANYL | TAKEDA CANADA INC | Solution | FENTANYL (FENTANYL CITRATE) 100 MCG | Cancelled Pre Market |
| 02408562 | INSTANYL | TAKEDA CANADA INC | Solution | FENTANYL (FENTANYL CITRATE) 200 MCG | Cancelled Pre Market |
| 02408546 | INSTANYL | TAKEDA CANADA INC | Solution | FENTANYL (FENTANYL CITRATE) 50 MCG | Cancelled Pre Market |
| 02350718 | ONSOLIS | MEDA AB | Film (Soluble) | FENTANYL (FENTANYL CITRATE) 800 MCG | Cancelled Post Market |
| 02350696 | ONSOLIS | MEDA AB | Film (Soluble) | FENTANYL (FENTANYL CITRATE) 600 MCG | Cancelled Post Market |
| 02350688 | ONSOLIS | MEDA AB | Film (Soluble) | FENTANYL (FENTANYL CITRATE) 400 MCG | Cancelled Post Market |
| 02350661 | ONSOLIS | MEDA AB | Film (Soluble) | FENTANYL (FENTANYL CITRATE) 200 MCG | Cancelled Post Market |
| 02350726 | ONSOLIS | MEDA AB | Film (Soluble) | FENTANYL (FENTANYL CITRATE) 1200 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37952 | 2026-07-22 | New Drug Submission (NDS) | Administrative: Change in product ownership |
| 14928 | 2013-11-21 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 14469 | 2013-06-14 | New Drug Submission (NDS) |